Telix Pharmaceuticals (TLX) Shares Outstanding (2024 - 2025)

Telix Pharmaceuticals (TLX) has disclosed Shares Outstanding for 2 consecutive years, with $338.8 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 54.77% to $338.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $338.8 million through Dec 2025, up 54.77% year-over-year, with the annual reading at $338.8 million for FY2025, 54.77% up from the prior year.
  • Shares Outstanding for Q4 2025 was $338.8 million at Telix Pharmaceuticals, up from $218.9 million in the prior quarter.
  • The five-year high for Shares Outstanding was $338.8 million in Q4 2025, with the low at $218.9 million in Q4 2024.